Evidence map›Paper›PMID 33339267›Full record

ReviewPlants (Basel, Switzerland)2020

Multi-Therapeutic Potential of Naringenin (4',5,7-Trihydroxyflavonone): Experimental Evidence and Mechanisms.

Azher Arafah, Muneeb U Rehman, Tahir Maqbool Mir, Adil Farooq Wali, Rayeesa Ali, Wajhul Qamar, Rehan Khan, Ajaz Ahmad, Syed Sameer Aga, Saeed Alqahtani and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Plants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
4.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 129 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Natural Molecules for Brain Health and Resilience.International journal of molecular sciences · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Uncovering Anti-Melanoma Mechanisms ofInternational journal of molecular sciences · 2025
    Article
  11. Article
  12. Prunin: An Emerging Anticancer Flavonoid.International journal of molecular sciences · 2025
    Review
  13. Article
  14. Article
  15. Naringin vs.Antioxidants (Basel, Switzerland) · 2025
    Article
  16. Review
  17. Article
  18. An Updated Review Summarizing the Anticancer Potential of Naringenin.Endocrine, metabolic & immune disorders drug targets · 2025
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Azher ArafahDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box-2457, Riyadh-11451, Saudi Arabia.
Muneeb U RehmanDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box-2457, Riyadh-11451, Saudi Arabia.ORCID 0000-0002-9995-6576
Tahir Maqbool MirNational Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA.ORCID 0000-0002-7294-3660
Adil Farooq WaliDepartment of Pharmaceutical Chemistry, RAK College of Pharmaceutical Sciences, RAK Medical and Health Science University, Ras Al Khaimah 11171, UAE.ORCID 0000-0003-1555-2820
Rayeesa AliDivision of Veterinary Biochemistry, Faculty of Veterinary Science and Animal Husbandry, SKUAST-Kashmir, Alustang, Shuhama 190006, India.
Wajhul QamarDepartment of Pharmacology & Toxicology, and Central Lab, College of Pharmacy, King Saud University, P.O. Box-2457, Riyadh 11451, Saudi Arabia.
Rehan KhanDepartment of Nano-therapeutics, Institute of Nano-science and Technology (DST-INST), Mohali, Punjab 160047, India.
Ajaz AhmadDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box-2457, Riyadh-11451, Saudi Arabia.
Syed Sameer AgaDepartment of Basic Medical Sciences, College of Medicine, King Saud bin Abdulaziz University (KSAU-HS), King Abdullah International Medical Research Centre (KAIMRC), Ministry of National Guard Health Affairs (NGHA), Jeddah 21423, Saudi Arabia.
Saeed AlqahtaniDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box-2457, Riyadh-11451, Saudi Arabia.ORCID 0000-0002-3839-8187
Nada M AlmatroudiDepartment of Clinical Pharmacy, College of Pharmacy Girls Campus, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
King Saud University · SASher-e-Kashmir University of Agricultural Sciences and Technology of Kashmir · INInstitute of Nano Science and TechnologyKing Saud bin Abdulaziz University for Health Sciences · SARas al-Khaimah Medical and Health Sciences University · AEUniversity of Mississippi · US

Funding

King Saud University RG-1441-397
6 · The paper itself

Abstract

Extensive research has been carried out during the last few decades, providing a detailed account of thousands of discovered phytochemicals and their biological activities that have the potential to be exploited for a wide variety of medicinal purposes. These phytochemicals, which are pharmacologically important for clinical use, primarily consist of polyphenols, followed by terpenoids and alkaloids. There are numerous published reports indicating the primary role of phytochemicals proven to possess therapeutic potential against several diseases. However, not all phytochemicals possess significant medicinal properties, and only some of them exhibit viable biological effects. Naringenin, a flavanone found in citrus fruits, is known to improve immunity, repair DNA damage, and scavenge free radicals. Despite the very low bioavailability of naringenin, it is known to exhibit various promising biological properties of medicinal importance, including anti-inflammatory and antioxidant activities. This review focuses on the various aspects related to naringenin, particularly its physicochemical, pharmacokinetic, and pharmacodynamic properties. Furthermore, various pharmacological activities of naringenin, such as anticancer, antidiabetic, hepatoprotective, neuroprotective, cardioprotective, nephroprotective, and gastroprotective effects, have been discussed along with their mechanisms of action.

Indexed as

naringeninnatural medicinepharmacologyphytochemistrypolyphenols

Identifiers

PMID33339267
PMCPMC7766900
OpenAlexW3112326155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.